Nov. 20, 2018
Litera Microsystems has announced Global Blood Therapeutics, a global biopharma company headquartered in San Francisco, CA, has recently chosen to implement DocXtools and Change-Pro to enhance their medical writing workflow. The company will roll out the solution to its writers, accelerating the creation, review, and formatting of electronic common technical documents (eCTD).
Matt Miller, Litera Microsystems Director of Life Sciences Products, said, “We’re happy Global Blood Therapeutics is leveraging DocXtools and Change-Pro to reduce time spent drafting, reviewing, and finalizing eCTDs. We look forward to working with them as they continue to invest in the development and delivery of innovative treatments that provide hope to underserved patient communities.”
About Litera Microsystems
Litera Microsystems is the leading provider of software for drafting, proofreading, comparing, repairing, cleaning and securing documents in the legal and life sciences industries worldwide. Our core products empower users to generate, review, and distribute high-quality content quickly and securely, from any device. Today, Litera Microsystems supports thousands of document-intensive organizations across the globe, helping them satisfy the complex demands of clients and regulators.